Group 1 - The core issue in developing new productive forces is the structural mismatch between long-cycle, high-risk hard technology innovation and traditional finance's pursuit of short-term returns [1] - The introduction of "patient capital" in central documents since 2024 indicates a clear policy direction, with a series of documents in early 2026 establishing rigid constraints for government investment funds to focus on early, small, long-term investments in hard technology [1][2] - Nanjing serves as a national-level pilot zone for sci-tech financial reform, showcasing the implementation of national strategies at the local level [1][4] Group 2 - The primary challenge in developing patient capital is overcoming barriers to investment and clarifying responsibilities, particularly for state-owned capital, which faces institutional conflicts between short-term asset preservation and long-term innovation investments [2][3] - The "Government Investment Fund Direction Evaluation Management Measures (Trial)" to be implemented in 2026 will increase the weight of policy compliance indicators to 60 points, aiming to shift the evaluation focus away from purely financial performance [2] - Nanjing's approach includes establishing clear rules to define risks and responsibilities, allowing for a maximum fund duration of 20 years for certain investment funds [2][3] Group 3 - The restructuring of the investment ecosystem emphasizes a shift from "single blood transfusion" to "system empowerment," with government investment funds expected to support major strategies and address market weaknesses [4] - Nanjing has arranged 30 billion yuan in mother funds, creating a "4+N" industrial fund cluster with a total scale exceeding 200 billion yuan, covering the entire investment lifecycle from concept validation to mergers and acquisitions [5] - The city has partnered with major financial asset investment companies to establish seven equity investment funds totaling over 3 billion yuan, forming a multi-level long-term capital supply system [5] Group 4 - Nanjing is expanding investment from mere financial support to comprehensive services, facilitating over 20 industrial innovation projects and reducing loan interest rates for tech companies [6] - The city has implemented a "technology research and development conversion insurance" to provide risk coverage for early-stage failures and established a direct investment fund for scene innovation [6] - A virtuous cycle of "investment—localization—reinvestment" is being realized, with many tech companies relocating headquarters or key R&D functions to Nanjing after receiving funding [6][7] Group 5 - Despite achieving initial success, further reforms are needed to ensure the effective implementation of patient capital, including establishing operational mechanisms for error tolerance and diversifying funding sources beyond state capital [8][9] - The exploration in Nanjing highlights the importance of balancing national strategies with market dynamics, emphasizing the need for precise institutional design to achieve a dynamic equilibrium [9] - The sustainability of "patient capital" relies on the effective integration of institutional interfaces, with ongoing efforts in Nanjing serving as a valuable case study [9]
以“耐心”之道 突围“硬科技”深水区——南京科创金融改革实践观察述评
Xin Hua Wang·2026-02-26 02:00